NASH Clinical Trials – Supporting the biggest phase 3 study in NASH
In a meta-analysis of several studies using various methodologies, worldwide prevalence of…
Read more
Oncology Clinical Trials
Opportunities for finding proper treatments for both solid tumors and onco-hematological malignancies…
Read more
Driving Excellence in Immuno-Oncology
Immuno-oncology and personalized medicine have sparked a new era in cancer research…
Read more
Protein Biomarkers
With some therapeutics proving ineffective in as many of 75% of patients,…
Read more
Strategic partnerships to provide unique solutions
Pharmaceutical and biotech companies are dealing with a paradigm shift in drug…
Read more
Africa: an advantageous landscape for conducting clinical trials
Africa has immense potential as an emerging market, and pharmaceutical and biotech…
Read more
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
No therapeutics have yet been proven effective for the treatment of severe…
Read more
Cerba Research, your partner in addressing the global COVID-19 pandemic
In light of the global COVID-19 (SARS-Cov-2) pandemic, the search for a…
Read more
Influenza Treatment Clinical Trial
We did a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and…
Read more
Drug-Resistant TB Clinical Trial
A partially blinded, randomized trial assessing the safety and efficacy of various…
Read more
Tuberculosis Clinical Trial
We did an open-label, partially randomized trial to evaluate the efficacy, safety…
Read more
Covid-19 Clinical Trial
Cerba Research performed a randomized, double-blind, placebo-controlled, trial to evaluate the efficacy…
Read more
Multiplex immunofluorescence detection of resident memory T cells in solid tumors
Tissue-resident memory T cells (TRM) represent a lineage of T cells localized…
Read more
In situ multiplex analysis of resident microglia and infiltrating macrophages in glioblastoma
Glioblastoma multiforme (GBM) is the most malignant primary brain tumor. Resident microglia…
Read more
Trial by ordeal of unprecedented global pandemic
Innovations in precision medicine have the potential to transform healthcare and create…
Read more
Did you know we are also present in Australia?
With Cerba’s network spanning five continents, team up with our experienced scientists…
Read more
Changing the shape of clinical trials
Cerba Research is the Belgian division of the French Group Cerba Healthcare.…
Read more
Non-Invasive Novel Biomarkers to Predict Alzheimer’s Risk
Since the National Institute on Aging and Alzheimer’s Association issued its 2011…
Read more
In situ multiplex analysis of regulatory and effector T cells in multiple tumor types
T cells are the most important immune effector cells and are therefore…
Read more
The complexity of myeloid-derived suppressor cells in non-small cell lung cancer: A combinatorial multiplex IHC and flow cytometry approach
Lung cancer is the leading cause of cancer deaths worldwide. Non-small cell…
Read more
Together, we can shape the future of your clinical development. Find out more about how we can support your research.
Contact Us